» Articles » PMID: 11553687

The Non-peptidyl Fungal Metabolite L-783,281 Activates TRK Neurotrophin Receptors

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2001 Sep 13
PMID 11553687
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Neurotrophin binding to the extracellular surface of the Trk family of tyrosine kinase receptors leads to the activation of multiple signalling cascades, culminating in neuroregenerative effects, including neuronal survival and neurite outgrowth. Since neurotrophins themselves are not ideal drug candidates due to their poor pharmacokinetic behaviour and bioavailability, small molecule neurotrophin mimetics may be beneficial in treating a number of neurodegenerative disorders. The present study demonstrates that L-783,281, a non-peptidyl fungal metabolite, is capable of stimulating TrkA, B and C phosphorylation to various extents in CHO cells stably expressing human Trk receptors. L-783,281 also stimulated Trk phosphorylation in a number of rat and human primary neuronal cultures, whereas the highly similar compound, L-767,827, was without effect. Mechanistic studies utilizing transiently transfected PDGF/TrkA and TrkA/PDGF chimeras, demonstrated that L-783,281 is likely to interact with the intracellular domain of the TrkA receptor. Further investigations suggested that L-783,281 was nevertheless able to instigate receptor dimerization by binding in a non-covalent manner. Although the cytotoxicity of the compound was shown to preclude its effects in neuronal survival and neurite outgrowth assays, it is a prototype for a small molecule neurotrophin mimetic that activates Trk by interacting at a site different from the neurotrophin-binding site.

Citing Articles

Calcium and Neural Stem Cell Proliferation.

Diaz-Pina D, Rivera-Ramirez N, Garcia-Lopez G, Diaz N, Molina-Hernandez A Int J Mol Sci. 2024; 25(7).

PMID: 38612887 PMC: 11012558. DOI: 10.3390/ijms25074073.


Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer's Disease.

Woodfield A, Gonzales T, Helmerhorst E, Laws S, Newsholme P, Porter T Int J Mol Sci. 2022; 23(24).

PMID: 36555450 PMC: 9779379. DOI: 10.3390/ijms232415811.


Activation of the insulin receptor by an insulin mimetic peptide.

Park J, Li J, Mayer J, Ball K, Wu J, Hall C Nat Commun. 2022; 13(1):5594.

PMID: 36151101 PMC: 9508239. DOI: 10.1038/s41467-022-33274-0.


Do Small Molecules Activate the TrkB Receptor in the Same Manner as BDNF? Limitations of Published TrkB Low Molecular Agonists and Screening for Novel TrkB Orthosteric Agonists.

Pankiewicz P, Szybinski M, Kisielewska K, Golebiowski F, Krzeminski P, Rutkowska-Wlodarczyk I Pharmaceuticals (Basel). 2021; 14(8).

PMID: 34451801 PMC: 8398766. DOI: 10.3390/ph14080704.


Identification of Novel Positive Allosteric Modulators of Neurotrophin Receptors for the Treatment of Cognitive Dysfunction.

Dahlstrom M, Madjid N, Nordvall G, Halldin M, Vazquez-Juarez E, Lindskog M Cells. 2021; 10(8).

PMID: 34440640 PMC: 8391421. DOI: 10.3390/cells10081871.